PFM Health Sciences, LP - Q2 2022 holdings

$2.62 Billion is the total value of PFM Health Sciences, LP's 80 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 45.6% .

 Value Shares↓ Weighting
JNJ BuyJOHNSON & JOHNSON$109,180,000
+5.3%
615,064
+5.2%
4.16%
+7.5%
CYTK  CYTOKINETICS INC$96,850,000
+6.7%
2,465,0160.0%3.70%
+8.9%
LLY  LILLY ELI & CO$96,829,000
+13.2%
298,6430.0%3.69%
+15.5%
CNC  CENTENE CORP DEL$94,127,000
+0.5%
1,112,4800.0%3.59%
+2.5%
JAZZ BuyJAZZ PHARMACEUTICALS PLC$89,228,000
+11.0%
571,936
+10.8%
3.40%
+13.2%
MRK NewMERCK & CO INC$88,617,000971,998
+100.0%
3.38%
HZNP  HORIZON THERAPEUTICS PUB L$87,085,000
-24.2%
1,091,8400.0%3.32%
-22.7%
RCUS SellARCUS BIOSCIENCES INC$84,799,000
-21.7%
3,346,458
-2.5%
3.24%
-20.1%
HUM  HUMANA INC$77,731,000
+7.6%
166,0660.0%2.96%
+9.7%
PFE  PFIZER INC$70,434,000
+1.3%
1,343,3840.0%2.69%
+3.3%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$69,559,000
+25.6%
839,371
+16.8%
2.65%
+28.2%
AVTR  AVANTOR INC$64,677,000
-8.0%
2,079,6570.0%2.47%
-6.2%
UNH  UNITEDHEALTH GROUP INC$57,297,000
+0.7%
111,5540.0%2.19%
+2.8%
IRTC  IRHYTHM TECHNOLOGIES INC$53,337,000
-31.4%
493,7210.0%2.04%
-30.0%
AXSM NewAXSOME THERAPEUTICS INC$52,111,0001,360,596
+100.0%
1.99%
SGEN NewSEAGEN INC$49,967,000282,395
+100.0%
1.91%
IQV  IQVIA HLDGS INC$48,106,000
-6.1%
221,6960.0%1.84%
-4.3%
DVAX  DYNAVAX TECHNOLOGIES CORP$47,910,000
+16.1%
3,805,3700.0%1.83%
+18.5%
 BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0$45,566,000
-0.9%
45,910,0000.0%1.74%
+1.0%
DHR  DANAHER CORPORATION$44,541,000
-13.6%
175,6900.0%1.70%
-11.8%
QURE BuyUNIQURE NV$41,686,000
+331.5%
2,236,370
+318.3%
1.59%
+340.4%
 AERIE PHARMACEUTICALS INCnote 1.500%10/0$41,088,000
-6.4%
48,150,0000.0%1.57%
-4.6%
MOH  MOLINA HEALTHCARE INC$40,202,000
-16.2%
143,7790.0%1.53%
-14.4%
VEEV NewVEEVA SYS INC$40,081,000202,387
+100.0%
1.53%
ICUI BuyICU MED INC$39,813,000
-18.9%
242,185
+9.8%
1.52%
-17.3%
ARGX NewARGENX SEsponsored adr$39,681,000104,732
+100.0%
1.51%
WAT  WATERS CORP$38,935,000
+6.6%
117,6340.0%1.48%
+8.8%
AZN BuyASTRAZENECA PLCsponsored adr$38,109,000
+27.0%
576,800
+27.5%
1.45%
+29.6%
ABBV NewABBVIE INC$37,713,000246,235
+100.0%
1.44%
CI BuyCIGNA CORP NEW$37,235,000
+65.1%
141,300
+50.1%
1.42%
+68.4%
MCK  MCKESSON CORP$34,517,000
+6.6%
105,8110.0%1.32%
+8.8%
ICLR  ICON PLC$34,278,000
-10.9%
158,1830.0%1.31%
-9.1%
NewBIOGEN INCcall$34,017,000166,800
+100.0%
1.30%
TMO  THERMO FISHER SCIENTIFIC INC$33,761,000
-8.0%
62,1430.0%1.29%
-6.2%
CAH  CARDINAL HEALTH INC$33,441,000
-7.8%
639,7830.0%1.28%
-5.9%
BuyERASCA INC$32,759,000
-20.5%
5,881,382
+22.7%
1.25%
-18.9%
BuyCARIBOU BIOSCIENCES INC$32,580,000
-18.8%
6,000,000
+37.3%
1.24%
-17.1%
BDX SellBECTON DICKINSON & CO$32,221,000
-23.1%
130,697
-17.1%
1.23%
-21.6%
EW  EDWARDS LIFESCIENCES CORP$32,155,000
-19.2%
338,1550.0%1.23%
-17.6%
UHS SellUNIVERSAL HLTH SVCS INCcl b$31,966,000
-50.0%
317,411
-28.1%
1.22%
-49.0%
NVRO BuyNEVRO CORP$28,902,000
-38.5%
659,410
+1.5%
1.10%
-37.2%
THC  TENET HEALTHCARE CORP$28,623,000
-38.9%
544,5830.0%1.09%
-37.6%
CTLT SellCATALENT INC$23,428,000
-17.5%
218,366
-14.7%
0.89%
-15.8%
BCRX NewBIOCRYST PHARMACEUTICALS INC$22,878,0002,162,411
+100.0%
0.87%
PEN BuyPENUMBRA INC$22,761,000
-38.5%
182,786
+9.6%
0.87%
-37.3%
MYGN SellMYRIAD GENETICS INC$21,391,000
-54.9%
1,177,250
-37.5%
0.82%
-54.0%
BAX NewBAXTER INTL INC$20,805,000323,907
+100.0%
0.79%
ANTM  ELEVANCE HEALTH INC$20,623,000
-1.8%
42,7340.0%0.79%
+0.3%
GBIO BuyGENERATION BIO CO$18,193,000
+331.6%
2,773,313
+382.9%
0.69%
+339.2%
PMVP BuyPMV PHARMACEUTICALS INC$17,302,000
+86.2%
1,214,164
+172.1%
0.66%
+90.2%
KRTX SellKARUNA THERAPEUTICS INC$16,483,000
-37.2%
130,293
-37.1%
0.63%
-35.9%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCsponds adr$15,487,000
+216.6%
9,109,780
+283.6%
0.59%
+223.0%
VERV BuyVERVE THERAPEUTICS INC$12,914,000
+53.0%
845,186
+128.6%
0.49%
+56.0%
NewKARUNA THERAPEUTICS INCcall$12,651,000100,000
+100.0%
0.48%
JNCE SellJOUNCE THERAPEUTICS INC$11,967,000
-55.6%
3,949,668
-0.6%
0.46%
-54.7%
NewPROCEPT BIOROBOTICS CORP$11,686,000357,492
+100.0%
0.45%
SNDX SellSYNDAX PHARMACEUTICALS INC$11,174,000
-68.5%
580,768
-71.6%
0.43%
-67.9%
ITOS NewITEOS THERAPEUTICS INC$11,082,000537,954
+100.0%
0.42%
OSH BuyOAK STR HEALTH INC$10,172,000
-27.7%
618,761
+18.2%
0.39%
-26.2%
BuyIO BIOTECH INC$10,083,000
+51.6%
2,159,155
+58.5%
0.38%
+54.6%
PRTA NewPROTHENA CORP PLC$9,370,000345,114
+100.0%
0.36%
ISEE SellIVERIC BIO INC$8,716,000
-48.5%
906,016
-9.9%
0.33%
-47.6%
NTLA SellINTELLIA THERAPEUTICS INC$8,451,000
-59.6%
163,280
-43.3%
0.32%
-58.8%
PRAX BuyPRAXIS PRECISION MEDICINES I$8,079,000
-8.5%
3,297,347
+281.3%
0.31%
-6.7%
NewDYNAVAX TECHNOLOGIES CORPnote 2.500% 5/1$7,479,0005,000,000
+100.0%
0.28%
EDIT NewEDITAS MEDICINE INC$7,449,000629,684
+100.0%
0.28%
HOWL BuyWEREWOLF THERAPEUTICS INC$7,079,000
+174.9%
1,730,723
+195.7%
0.27%
+181.2%
NewSEAGEN INCcall$7,078,00040,000
+100.0%
0.27%
NewSIGHT SCIENCES INC$6,979,000776,281
+100.0%
0.27%
SellSOPHIA GENETICS SAordinary shares$6,393,000
-58.9%
1,766,062
-12.3%
0.24%
-58.1%
SANA BuySANA BIOTECHNOLOGY INC$6,126,000
+108.7%
952,733
+168.2%
0.23%
+112.7%
NewBIOCRYST PHARMACEUTICALS INCcall$5,819,000550,000
+100.0%
0.22%
ACAD NewACADIA PHARMACEUTICALS INC$5,425,000384,995
+100.0%
0.21%
AERI SellAERIE PHARMACEUTICALS INC$5,246,000
-47.0%
699,531
-35.7%
0.20%
-45.9%
BLSA  BCLS ACQUISITION CORP$4,595,000
+0.3%
464,1030.0%0.18%
+2.3%
JYAC  JIYA ACQUISITION CORP$4,585,000
+0.5%
464,1030.0%0.18%
+2.3%
CMPS NewCOMPASS PATHWAYS PLCsponsored ads$4,250,000392,764
+100.0%
0.16%
EPIX NewESSA PHARMA INC$3,029,000961,716
+100.0%
0.12%
BuyPARDES BIOSCIENCES INC$2,460,000
-53.3%
801,204
+9.7%
0.09%
-52.3%
FLDM ExitFLUIDIGM CORP DEL$0-980,505
-100.0%
-0.13%
CCCC ExitC4 THERAPEUTICS INC$0-284,772
-100.0%
-0.26%
CANO ExitCANO HEALTH INC$0-1,301,937
-100.0%
-0.31%
GILD ExitGILEAD SCIENCES INC$0-249,884
-100.0%
-0.56%
DXCM ExitDEXCOM INC$0-37,021
-100.0%
-0.71%
HCA ExitHCA HEALTHCARE INC$0-80,128
-100.0%
-0.75%
HRTX ExitHERON THERAPEUTICS INC$0-3,512,348
-100.0%
-0.75%
SRRA ExitSIERRA ONCOLOGY INC$0-1,062,888
-100.0%
-1.27%
ExitGILEAD SCIENCES INCcall$0-1,412,500
-100.0%
-3.14%
OM ExitOUTSET MED INC$0-2,810,686
-100.0%
-4.77%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC41Q3 20232.2%
HCA HOLDINGS INC38Q3 20235.2%
HUMANA INC37Q3 20233.8%
EDWARDS LIFESCIENCES CORP36Q3 20233.3%
UNITEDHEALTH GROUP INC33Q3 20234.8%
PENUMBRA INC33Q3 20234.8%
AERIE PHARMACEUTICALS INC28Q2 20223.7%
TENET HEALTHCARE CORP27Q3 20232.3%
ELEVANCE HEALTH INC26Q3 20234.2%
ICON PLC26Q3 20232.5%

View PFM Health Sciences, LP's complete holdings history.

Latest significant ownerships (13-D/G)

View PFM Health Sciences, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-21

View PFM Health Sciences, LP's complete filings history.

Compare quarters

Export PFM Health Sciences, LP's holdings